FTC Should Ban Individual Impersonation Scams
TINA.org submits comment in support of FTC’s proposal to ban fake celebrity endorsements, romance scams and other impersonation scams.
A group of consumers who purchased Nexium, a heartburn medication, in Massachusetts since March 2001 filed a class-action lawsuit against AstraZeneca. They claimed that the pharmaceutical company deceptively marketed the medication as superior to its other heartburn drugs so that consumers would buy the more expensive Nexium. In October 2012, AstraZeneca agreed to settle the lawsuit but the terms of the settlement have not yet been announced. (Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Case No. 05-0269)
TINA.org submits comment in support of FTC’s proposal to ban fake celebrity endorsements, romance scams and other impersonation scams.
Looks can be deceiving.
Eric Lagatta, USA Today
Following a complaint by ad watchdog truthinadvertising.org (TINA.org), Pottery Barn’s parent company Williams-Sonoma has agreed to pay more than $3 million for violating a 2020 FTC consent order requiring that…
FTC says civil penalty against Williams-Sonoma is “the largest ever in a Made in USA case.”